NasdaqGS - Nasdaq Real Time Price USD

Twist Bioscience Corporation (TWST)

Compare
46.07 +1.00 (+2.22%)
As of 1:27 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 75.3M
Earnings -45.49M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

45.00
52.79 Average
46.07 Current
62.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1071112
Avg. Estimate -0.71-0.64-3.55-2.43
Low Estimate -0.75-0.76-3.76-2.76
High Estimate -0.67-0.39-2.9-2.09
Year Ago EPS -0.81-0.75-3.6-3.55

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1091212
Avg. Estimate 82.2M84.79M310.76M371.95M
Low Estimate 78M81M310M352M
High Estimate 83.6M88.4M311.8M388.4M
Year Ago Sales 66.95M67.58M245.11M310.76M
Sales Growth (year/est) 22.80%25.50%26.80%19.70%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. -0.92-0.78-0.82-0.76
EPS Actual -0.81-0.75-0.79-1.47
Difference 0.110.030.03-0.71
Surprise % 12.00%3.80%3.70%-93.40%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.71-0.64-3.55-2.43
7 Days Ago -0.71-0.65-3.54-2.42
30 Days Ago -0.71-0.65-3.54-2.41
60 Days Ago -0.71-0.65-3.55-2.39
90 Days Ago -0.71-0.67-3.01-2.47

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --1----
Up Last 30 Days --1--1
Down Last 7 Days --------
Down Last 30 Days 1--11

Growth Estimates

CURRENCY IN USD TWSTIndustrySectorS&P 500
Current Qtr. 12.30%----4.10%
Next Qtr. 14.70%----7.60%
Current Year 1.40%----2.50%
Next Year 31.50%----13.10%
Next 5 Years (per annum) 150.00%----11.89%
Past 5 Years (per annum) --------

Upgrades & Downgrades

Maintains Leerink Partners: Market Perform to Market Perform 10/17/2024
Maintains Evercore ISI Group: Outperform to Outperform 10/1/2024
Maintains Barclays: Overweight to Overweight 8/5/2024
Maintains JP Morgan: Underweight to Underweight 8/5/2024
Maintains Baird: Outperform to Outperform 8/5/2024
Maintains Goldman Sachs: Buy to Buy 7/9/2024

Related Tickers